NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/25/2025
Back to search
Official data from USPTO
LINDUS HEALTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LINDUS HEALTH
ST13
US500000098032355Class
35, 42, 45
Filing
98032355
Registration
7700807
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
04/03/2025
Trademark type
Word
Nice classes
35, 42, 45
Filing date
06/07/2023
Registration date
02/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2025
Last transaction
04/03/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
LONDON, GB
Examiner
SIMCOX,KYLE DUNCAN
Law office
N40
Current location
PETITIONS OFFICE
Holders and representatives
Holders
Lindus Health Ltd.
Representatives
RYAN S. HILBERT HOLLEY & MENKER PA
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing independent review of clinical trials for business purposes for the purpose of improvingconsulting onorganizingmanaging and optimizing clinical trials; Business consulting and management in the field of clinical trialsmanagement and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting services in the field of clinical trials; Business advisory services in the field of clinical trials; Business information services in the field of clinical trials; none of the foregoing consisting of marketingmarketing consulting and market research services in the fields of bio- technology and the life sciences
Class 42
Platform as a service (PAAS) featuring software for use in collectinganalyzingprocessingtrackingsynthesizingstoringorganizingexchangingsharingreportingtransmitting and distributing informationdataimagesaudiovideo and audiovisual materials in the fields of clinical research and clinical trials; Software as a service (SAAS) featuring software for use in collectinganalyzingprocessingtrackingsynthesizingstoringorganizingexchangingsharingreportingtransmitting and distributing informationdataimagesaudiovideo and audiovisual materials in the fields of clinical research and clinical trials; Technical support servicesinstallation and remote administration of softwaretroubleshooting of software problems and hosted software applicationsall for use in connection with clinical research and clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific researchconducting clinical trials for others; Medical and scientific researchdesigningorganizingconductingmonitoringmanaging clinical trials and studies for others; Providing information in the fields of clinical research and clinical trials via a website
Class 45
Tracking and monitoring regulatory requirements in the pharmaceuticalbiotechnologymedical fields for legal or regulatory compliance purposes; Tracking and monitoring regulatory requirements in the field of drug and device development and manufacturing for regulatory compliance purposes
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2025
TMBN
TTAB RELEASE CASE TO TRADEMARKS
02/03/2025
OP.T
OPPOSITION TERMINATED NO. 999999
02/03/2025
OP.D
OPPOSITION DISMISSED NO. 999999
02/03/2025
CHPB
POST PUBLICATION AMENDMENT - ENTERED
09/30/2024
APET
ASSIGNED TO PETITION STAFF
09/30/2024
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
09/19/2024
OP.I
OPPOSITION INSTITUTED NO. 999999
09/19/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/17/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
06/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/21/2024
PUBO
PUBLISHED FOR OPPOSITION
05/21/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/11/2024
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
03/18/2024
GPRA
PRIORITY ACTION E-MAILED
03/18/2024
CPRA
PRIORITY ACTION WRITTEN
03/18/2024
DOCK
ASSIGNED TO EXAMINER
02/27/2024
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
02/09/2024
ALIE
ASSIGNED TO LIE
02/09/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/19/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2023
NWAP
NEW APPLICATION ENTERED
06/10/2023
Continuous trademark protection
Get notified about every new filing that threatens LINDUS HEALTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.